EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Blood–Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions

Fangsong Zhang, Jianye Zhang, Xuexue Wang, Mengyang Han, Yi Fei, Jinhong Wang iD

International Journal of Molecular Sciences · 21.01.2025 · 26 (3) · 873

DOI: 10.3390/ijms26030873 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.01.2025. Verfasst von Fangsong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai 20003…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Schizophrenia. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The blood–brain barrier (BBB) plays a crucial role in maintaining the homeostasis of the central nervous system by regulating solute transport and preventing neurotoxic substances from infiltrating brain tissue. In schizophrenia, emerging evidence identifies BBB dysfunction as a key pathophysiological factor associated with neuroinflammation, tight junction abnormalities, and endothelial dysfunction. Recent advancements in neuroimaging techniques, such as arterial spin labeling (ASL), have provided valuable tools for investigating BBB permeability and its role in disease progression. This review synthesizes findings from postmortem studies, serum and cerebrospinal fluid biomarker analyses, and advanced neuroimaging research to elucidate BBB alterations in schizophrenia. It highlights the mechanistic roles of tight junction protein dysregulation, neurovascular unit dysfunction, and immune responses in disrupting BBB integrity. Furthermore, the review examines the bidirectional effects of antipsychotic medications on BBB, addressing both therapeutic opportunities and potential challenges. By emphasizing the pivotal role of BBB dysfunction in schizophrenia pathogenesis, this review underscores its translational potential. Through the integration of multidisciplinary evidence, it lays the foundation for innovative diagnostic approaches and therapeutic strategies, enhancing our understanding of schizophrenia’s complex pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierSchizophreniaHumansAnimalsBiomarkersTight JunctionsAntipsychotic Agents

Stichwörter der Autor:innen

ASLMRIbiomarkersblood–brain barrierendothelial dysfunctionneuroimagingneuroinflammationpathophysiologyschizophreniatight junction

Substanzen

BiomarkersAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Medical Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai 200030, China.

ORCID-Profile: Jinhong Wang

Zitieren

APA

Zhang, F., Zhang, J., Wang, X., Han, M., Fei, Y., & Wang, J. (2025). Blood–Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions. International Journal of Molecular Sciences, 26(3), 873. https://doi.org/10.3390/ijms26030873

Vancouver

Zhang F, Zhang J, Wang X, Han M, Fei Y, Wang J. Blood–Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions. International Journal of Molecular Sciences. 2025;26(3):873. doi:10.3390/ijms26030873

BibTeX
@article{Zhang2025,
  author = {Zhang, Fangsong and Zhang, Jianye and Wang, Xuexue and Han, Mengyang and Fei, Yi and Wang, Jinhong},
  title = {Blood–Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {3},
  pages = {873},
  doi = {10.3390/ijms26030873}
}
Kostenlos starten →